These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15779417)

  • 1. [Selection of oral antidiabetic drugs].
    Iwamoto Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():428-32. PubMed ID: 15779417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
    Kawamori R; Kadowaki T; Ishida H
    Nihon Rinsho; 2004 Apr; 62(4):831-9. PubMed ID: 15106356
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Study TO Prevent Non-Insulin Dependent Diabetes Mellitus trial (acarbose)].
    Nishimura R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():478-82. PubMed ID: 15779425
    [No Abstract]   [Full Text] [Related]  

  • 4. [Measures to meet the side effects of the orally administered antihyperglycemic drugs].
    Ishii J; Inoue I
    Nihon Rinsho; 1997 Nov; 55 Suppl():104-13. PubMed ID: 9434452
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapies for newly-onset diabetic patients].
    Kawamori R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():525-32. PubMed ID: 15779435
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral hypoglycemic agents--overview].
    Sakamoto N; Uno T
    Nihon Rinsho; 1997 Nov; 55 Suppl():94-8. PubMed ID: 9434450
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pitfalls in treatment with oral antidiabetic agents].
    Perusicová J
    Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current and future aspects of oral antidiabetic agents in type 2 diabetes].
    Rybka J
    Vnitr Lek; 2001 May; 47(5):285-90. PubMed ID: 11395869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse effects of oral hypoglycemic agents].
    Mori Y; Sekihara H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():325-31. PubMed ID: 12387013
    [No Abstract]   [Full Text] [Related]  

  • 11. What does the Acarbose Cardiovascular Evaluation (ACE) trial tell us?
    Holman RR
    J Diabetes; 2018 Aug; 10(8):683-685. PubMed ID: 29774661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy in subjects with impaired glucose tolerance].
    Kawamori R; Yoshii H
    Nihon Rinsho; 1996 Oct; 54(10):2750-3. PubMed ID: 8914439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
    Sakamoto N; Tajima N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination therapy with biguanides].
    Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological treatment of type 2 diabetes.
    Hermans MP; Buysschaert M
    Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral combination therapy for type 2 diabetes.
    Charpentier G
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S70-6. PubMed ID: 12324989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic profile of oral antidiabetic agents].
    Okubo M; Yamane K; Kohno N
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristic of metformin for treatment of impaired glucose tolerance].
    Ishida W; Satoh J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of oral hypoglycemic agents on platelet function.
    Papazafiropoulou A; Papanas N; Pappas S; Maltezos E; Mikhailidis DP
    J Diabetes Complications; 2015 Aug; 29(6):846-51. PubMed ID: 26026848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of voglibose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
    Nakamura J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():457-61. PubMed ID: 15779422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.